Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Review Article
Author Details :
Volume : 10, Issue : 2, Year : 2024
Article Page : 206-212
https://doi.org/10.18231/j.ijceo.2024.038
Abstract
Artificial intelligence (AI) has made significant strides in various fields, particularly in ophthalmology, in recent years. This article examines the state-of-the-art in the domain of ophthalmology in order to define the vision that will allow us to advance scientifically in this digital age. The rigorous yet approachable
introduction to the algorithms that serve as the foundation for all current AI applications opens the paper. Subsequently, an extensive assessment of the primary AI uses in ophthalmology is given, including subjects like diabetic retinopathy, age-related macular degeneration, glaucoma, and retinopathy of prematurity. The assessment concludes with a brief discussion of the prospects and difficulties this industry may face in the future.
Keywords: Machine learning, Deep learning, Convolutional neural networks, Keratoconus, Diabetic retinopathy, Glaucoma, Cataract surgery.
How to cite : Sharma A, Raj A, Nishant P, Maurya R P, Artificial intelligence in ophthalmology: Current status. Indian J Clin Exp Ophthalmol 2024;10(2):206-212
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.